Multiple sclerosis and cancer in Norway a retrospective cohort study

Acta Neurologica Scandinavica

Volumn 93, Issue 6, 1996, Pages 411-415

  Midgard, R ^a   Glattre, E ^b   Gronning M ^c   Riise, T ^c   Edland, A ^d   Nyland, H ^c  

^a Molde County Hospital   (Norway)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d Buskerud Central Hospital   (Norway)

Author keywords

Multiple sclerosis; Neoplasms; Record linkage; Retrospective population based cohort study

Indexed keywords

ADULT; ARTICLE; CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; RISK FACTOR;

EID: 0030055974     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1996.tb00019.x     Document Type: Article

References (31)

1. ALLEN IV, MILLAR JHD, HUTCHINSON MJ. General disease in 120 necropsy-proven cases of multiple sclerosis. Neuropathol and Appl Neurobiol 1978: 4: 279-284.
2. ZIMMERMANN HM, NETSKY MG. The pathology of multiple sclerosis. In: Multiple sclerosis. Research Publications of the Association for research into Nervous and Mental Disease. 1950: 271-312.
3. PALO J, DUCHESNE J, WIKSTRÖM J. Malignant disease among patients with multiple sclerosis. J Neurol 1977: 216: 217-222.
4. ANDERSON M, HUGHES B, JEFFERSON M, SMITH WT, WATERHOUSE JAH. Gliomatous transformation and demyelinating diseases. Brain 1980: 103: 603-622.
5. KINLEN LJ. Immunosuppressive therapy and cancer. Cancer Surv 1982: 1: 565-583.
6. LHERMITTE F, MARTEAU R, ROULLET G. Not so benign long-term immunosuppression in multiple sclerosis? Lancet 1984: 1: 276-277.
7. MALMGREN RM, DETELS R, VERITY MA. Co-occurrence of multiple sclerosis and glioma: case report and neuropathologic and epidemiologic review. Clin Neuropathol 1984: 3: 1-9.
8. MØLLER H, KNELLER RW, BOICE JD, OLSEN JH. Cancer incidence following hospitalization for multiple sclerosis in Denmark. Acta Neurol Scand 1991: 84: 214-220.
9. PERCY AK, NOBREGA FT, OKAZAKI H, GLATTRE E, KURLAND LT. Multiple sclerosis in Rochester, Minnesota. A 60-year appraisal. Arch Neurol 1971: 25: 105-111.
10. WYNN DR, RODRIGUEZ M, O'FALLON M, KURLAND LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990: 40: 780-786.
11. LARSEN JP, AARLI JA, NYLAND H, RIISE T. Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland. Neurology 1984: 34: 1202-1207.
12. GRØNNING M, RIISE T, KVÅLE G, NYLAND H, LARSEN JP, AARLI JA. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern. Neuroepidemiology 1991: 10: 53-61.
13. MIDGARD R, RUSE T, NYLAND H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 1991: 41: 887-892.
14. MIDGARD R, RIISE T, SVANES C, KVÅLE G, NYLAND H. Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis. Brain 1996: 119: 203-211.
15. EDLAND A, RIISE T, NYLAND H. Multiple sclerosis in Vestfold County, Norway. Acta Neurol Scand (accepted).
16. DIXON WJ, BROWN MB, ENGELMAN ET, HILL MA, JENNRICH RI. BMDP statistical software manual. Berkeley: University of California Press, 1990.
17. PRESTON DL, LUBIN JH, PIERCE DA. EPICURE: risk regression and data analysis software. Seattle, Washington: Hirosoft International Corp., 1990.
18. MATTHEWS WB. Some aspects of the natural history. In: Matthews WB, Compston A, Allen IV, Martyn CN., eds. McAlpine's multiple sclerosis. Edinburgh: Churchill Livingstone 1991: 109-112.
19. KVÅLE G. Reproductive factors in breast cancer epidemiology. Acta Oncol 1992: 31: 187-194.
20. ALBREKTSEN G, HEUCH I, TRETLI S, KVÅLE G. Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million Norwegian women. Epidemiology 1994: 5: 604-611.
21. ALBREKTSEN G, HEUCH I, KVÅLE G. The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women. Br J Cancer 1995: 72: 480-484.
22. ALBREKTSEN G, HEUCH I, TRETLI S, KVÅLE G. Is the risk of cancer of the corpus uteri reduced by a recent pregnancy ? A prospective study of 765,756 Norwegian women. Int J Cancer 1995: 61: 485-490.
23. RIISE T, GRØNNING M, KLAUBER MR, BARRETT-CONNOR E, NYLAND H, ALBREKTSEN G. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. Am J Epidemiol 1991: 133: 932-939.
24. MARTYN CN, CRUDDAS M, COMPSTON DAS. Symptomatic Epstein-Barr virus infection and multiple sclerosis. J Neurol Neurosurg Psychiatry 1993: 56: 167-168.
25. EVANS AS. Viruses. In: Sclottenfeld D, Fraumeni JF jr., eds. Cancer epidemiology and prevention. Philadelphia: Saunders 1982: 376-377.
26. VARMUS H. Retroviruses. Science 1988: 240: 1427-1435.
27. HAAHEIM LR, GRØNNING M, NYLAND H. Antibodies in sera from Norwegian multiple sclerosis patients and the general population reacting with HTLV-I. A pilot study. Acta Pathol Microbiol Scand 1989: 97: 767-773.
28. MYHR KM, FROST P, GRØNNING M, et al. Absence of HTLV-1 related sequences in MS from high prevalence areas in Western Norway. Acta Neurol Scand 1994: 89: 65-68.
29. MILLER H, SIMPSON CA, YEATES WK. Bladder dysfunction in multiple sclerosis. Br Med J 1965: 1: 1265-1269.
30. ROBERTSON DAF, LOW-BEER TS. Long-term consequences of arsenical treatment of multiple sclerosis. Br Med J 1983: 286: 605-606.
31. HAUSER SL, DAWSON DM, LEHRICH JR et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983: 308: 173-180.